She completed her medical studies, PhD and international health competence in Helsinki. She serves as secretary of the Finnish NITAG, and the subgroup of the Strategic development of influenza vaccination programme. In addition, she practices clinical medicine at the travel health clinic Aava, Helsinki. She was instrumental in designing the HPV vaccine introduction to the national immunization programme. Her research interests are register based vaccine impact studies, evidence based policy/decision making, vaccine safety, hesitancy, RSV, influenza, and pneumococcus. She coordinates the workpackage on communications in IMI DRIVE (www.drive-eu.org). She has authored >130 original articles (incl first scientific report on association between pandemic influenza vaccination vs narcolepsy), and teaches, guides elective, graduate, and PhD students. She has served expert committees evaluating HBV, PCV, rota virus vaccine in Finland, and as advisor to EU, IMI, IVI, WHO, GAVI, SIDA/SRC, Finnish MOFA. She was the Chairman of the WHO SAGE external evaluation (EAGSE), Chairman EPIET 1998-2001, EDCTP 2002-3. She presently is a member of WHO SAGE subgroup Influenza Vaccines, a member of the ECDC NITAG coordinating committee, and Vice chair and Board Member International Vaccine Institute. She belongs to the Faculty of ADVAC since its initiation 2000-, and initiated the EPIET vaccine module 1997, and Finnish Diploma Course Global Health 2000.